Please do not leave this page until complete. This can take a few moments.
As Massachusetts enters the second month of March to be shaded by the coronavirus pandemic, the number of people here who have been fully vaccinated is roughly equal to the number of people who have been infected with COVID-19 over the last year.
The equivalent of the population of Methuen -- roughly 51,000 people -- got their second dose of a COVID-19 vaccine between Friday's report from the Department of Public Health and Sunday's update. There are 550,000 people fully vaccinated against the coronavirus, Gov. Charlie Baker said Monday morning, compared to 550,302 total confirmed COVID-19 infections since the start of the pandemic.
With more than 1.2 million residents having received at least one vaccine dose, Massachusetts is again beginning to reopen its economy more widely and a third vaccine approved by federal officials over the weekend could help alleviate some of the tensions that come with the limited supply of doses.
The U.S. Food and Drug Administration issued an emergency use authorization Saturday for the one-shot Johnson & Johnson vaccine, which was developed in part by a group at Beth Israel Deaconess Medical Center in Boston. It joins the Moderna and Pfizer two-dose vaccines in the public health arsenal and states are expected to receive an initial batch of the doses this week.
"Our healthcare leaders and clinicians see the authorization of the Johnson & Johnson vaccine as a significant step forward in the effort to vaccinate residents of the commonwealth," Valerie Fleishman, senior vice president and chief innovation officer at the Massachusetts Health & Hospital Association, said. "This vaccine has been shown to be highly effective in protecting against COVID-19-related hospitalizations and deaths, and those who receive it should have every confidence that they are protected against serious illness due to COVID-19 and its variants."
Johnson & Johnson is expected to deliver about 20 million doses of its single-shot COVID-19 vaccine to the federal government for distribution by the end of March. The New York Times reported Monday morning that Biden administration officials speaking on background said that the company will deliver 3.9 million shots this week but none next week.
Baker said last week the combination of Johnson & Johnson's vaccine getting approval and the plans Pfizer and Moderna have to increase their production "could be a really big moment."
On Monday, Baker said the new vaccine "will certainly dramatically boost" the state's vaccination efforts and "should mean a big increase" in the amount of vaccine available.
On Feb. 24, Baker estimated it would take about a month, barring an increase in vaccine supply, to get through the roughly 1 million people who at that time were becoming newly eligible to receive vaccines, including the large group of residents in the age 65 and older group.
Also on Monday, Baker said about 68 percent of residents 75 and older had been vaccinated. In the long-term care sector, 90 percent of residents and about 70 percent of staff had received vaccines, he said.
As of Monday morning, Massachusetts moved back to Step 2 of Phase III of the administration's reopening plan, which means that occupancy limits broadly increase to 50 percent for most businesses and indoor performance venues and indoor recreational activities can reopen. Restaurants no longer have a percent-based capacity restriction but must adhere to six-foot social distancing, limits of six people per table and 90-minute limits.
U.S. Centers for Disease Control and Prevention Director Dr. Rochelle Walensky, who was the head of Massachusetts General Hospital's infectious disease division before being tapped for her federal role, was specifically asked about Baker's newest rules for restaurants Friday and said her agency "would really encourage people and states to not expand and release restrictions."
"Given the trends that we've seen in just the last couple of days, I would say, you know, we can't be in a place where we're lifting restrictions right now," she said, according to a transcript provided by the White House. "If we level off at the level of 70,000 cases a day, we are just at the level where -- where we had the peak before -- or base before we have the fall peak."
Over the weekend in Massachusetts, 2,944 people were newly confirmed to be infected with COVID-19 and the state announced the recent COVID-19 deaths of 93 more people. There are 760 people hospitalized with COVID-19 in Massachusetts and the state estimates that just more than 30,000 residents currently have active and contagious cases of the respiratory disease.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments